Ductal Carcinoma in Situ of the Breast
August 2017 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Ductal Carcinoma in Situ of the Breast abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Ductal Carcinoma in Situ of the Breast. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Ductal Carcinoma in Situ of the Breast. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Ductal Carcinoma in Situ of the Breast every 3 months. Thank you for your ongoing subscription to this publication.

Sincerely,
Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
Authors:Martinez-Perez C, Turnbull AK, Ekatah GE, Arthur LM, Sims AH, Thomas JS, Dixon JM
Institution:Breast Cancer Now Edinburgh Research Team, Western General Hospital, University of Edinburgh, United Kingdom. Electronic address: carlos.martinez-perez@igmm.ed.ac.uk. of Edinburgh, United Kingdom. Kingdom. of Edinburgh, United Kingdom. of Edinburgh, United Kingdom. Kingdom.
Journal:Cancer Treat Rev. 2017 Apr;55:163-172. doi: 10.1016/j.ctrv.2017.03.009. Epub 2017 Mar 31.

2:Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box.
Authors:Lazzeroni M, Dunn BK, Pruneri G, Jereczek-Fossa BA, Orecchia R, Bonanni B, DeCensi A
Institution:Divisions of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. USA. and Hemato-Oncology, University of Milan, Italy. Oncology and Hemato-Oncology, University of Milan, Italy. Oncology and Hemato-Oncology, University of Milan, Italy. Milan, Italy. Milan, Italy; Division of Medical Oncology, E.O. Ospedali Galliera, Genoa, Italy; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, United Kingdom. Electronic address: andrea.decensi@galliera.it.
Journal:Cancer Treat Rev. 2017 Apr;55:1-9. doi: 10.1016/j.ctrv.2017.01.010. Epub 2017 Feb 11.

3:Precision surgery and avoiding over-treatment.
Authors:Hosseini A, Khoury AL, Esserman LJ
Institution:University of California, 1600 Divisadero, 2nd Floor Box 1710, San Francisco, CA 94115, USA. Electronic address: Ava.hosseini@ucsf.edu. 94115, USA. Electronic address: amal.khoury@ucsf.edu. 94115, USA. Electronic address: laura.esserman@ucsf.edu.
Journal:Eur J Surg Oncol. 2017 May;43(5):938-943. doi: 10.1016/j.ejso.2017.02.003. Epub 2017 Feb 11.

4:DCIS and axillary nodal evaluation: compliance with national guidelines.
Authors:Mitchell KB, Lin H, Shen Y, Colfry A, Kuerer H, Shaitelman SF, Babiera GV, Bedrosian I
Institution:Department of Breast Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. Houston, TX, USA. Houston, TX, USA. Center, Houston, TX, 77030, USA. Center, Houston, TX, 77030, USA. Houston, TX, USA. Center, Houston, TX, 77030, USA.
Journal:BMC Surg. 2017 Feb 7;17(1):12. doi: 10.1186/s12893-017-0210-5.

5:Short term safety of oncoplastic breast conserving surgery for larger tumors.
Authors:Wijgman DJ, Ten Wolde B, van Groesen NR, Keemers-Gels ME, van den Wildenberg FJ, Strobbe LJ
Institution:Department of Surgical Oncology, B58, Canisius Wilhelmina Ziekenhuis, Weg door Jonkerbos 100, 6532 SB Nijmegen, The Netherlands. Electronic address: janneke.wijgman@gmail.com. 6500 HB Nijmegen, The Netherlands. Electronic address: Britt_tenWolde@hotmail.com. Jonkerbos 100, 6532 SB Nijmegen, The Netherlands. Electronic address: nravangroesen@gmail.com. Jonkerbos 100, 6532 SB Nijmegen, The Netherlands. Electronic address: m.keemers@cwz.nl. Jonkerbos 100, 6532 SB Nijmegen, The Netherlands. Electronic address: f.v.d.wildenberg@cwz.nl. Jonkerbos 100, 6532 SB Nijmegen, The Netherlands. Electronic address: ljastrobbe@cwz.nl.
Journal:Eur J Surg Oncol. 2017 Apr;43(4):665-671. doi: 10.1016/j.ejso.2016.11.021. Epub 2016 Dec 18.

6:Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
Authors:Jagsi R, Hawley ST, Griffith KA, Janz NK, Kurian AW, Ward KC, Hamilton AS, Morrow M, Katz SJ
Institution:Department of Radiation Oncology, University of Michigan, Ann Arbor. Health Management and Policy, University of Michigan, Ann Arbor4Ann Arbor Veterans Affairs Health Care System, Ann Arbor. of Public Health, Ann Arbor. York. Health Management and Policy, University of Michigan, Ann Arbor.
Journal:JAMA Surg. 2017 Mar 1;152(3):274-282. doi: 10.1001/jamasurg.2016.4749.

7:Identifying progression predictors of breast ductal carcinoma in situ.
Authors:Yeong J, Thike AA, Tan PH, Iqbal J
Institution:Division of Pathology, Singapore General Hospital, Singapore, Singapore. (A*STAR), Singapore, Singapore.
Journal:J Clin Pathol. 2017 Feb;70(2):102-108. doi: 10.1136/jclinpath-2016-204154. Epub 2016 Nov 18.

8:Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Authors:Groen EJ, Elshof LE, Visser LL, Rutgers EJ, Winter-Warnars HA, Lips EH, Wesseling J
Institution:Department of Pathology, Division of Diagnostic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, The Netherlands. Leeuwenhoek Hospital, The Netherlands. Leeuwenhoek Hospital, The Netherlands. Leeuwenhoek Hospital, The Netherlands. Institute-Antoni van Leeuwenhoek Hospital, The Netherlands. Leeuwenhoek Hospital, The Netherlands. Institute-Antoni van Leeuwenhoek Hospital, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, The Netherlands. Electronic address: j.wesseling@nki.nl.
Journal:Breast. 2017 Feb;31:274-283. doi: 10.1016/j.breast.2016.09.001. Epub 2016 Sep 23.

9:Ductal carcinoma in situ: Is core needle biopsy ever enough?
Authors:Caswell-Smith P, Wall M
Institution:Department of Radiology, Wellington Regional Hospital, Wellington, New Zealand.
Journal:J Med Imaging Radiat Oncol. 2017 Feb;61(1):29-33. doi: 10.1111/1754-9485.12503. Epub 2016 Aug 23.

For a FREE PREVIEW of the Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast...
at a Special 20% Discount


Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast

Updated: June 20, 2017
154 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

DC72633434

Coupon Expires: October 25, 2017



What Our Customers Are Saying...

"The MediFocus Guidebook on DCIS was more than adequate for my research on this condition and I would recommend it to anyone wanting the "whole picture". Thank you for providing this excellent service."
C.M.
Los Angeles, California


"At a very difficult time, your MediFocus Guidebook on Ductal Carcinoma in Situ helped our family make informed decisions. Thank you for your help!"
M.A.L.
Metarie, Louisiana


"I was recently diagnosed with DCIS and was looking everywhere for information to get myself educated. The MediFocus Guidebook was very helpful in clarifying everything for me. The information is so well organized that it makes it easy to read and understand. I feel much better now that I've read this Guidebook and have a clearer understanding of the issues that I face. I highly recommend this Guidebook to anyone seeking to understand DCIS."
C.G.
Ft. Lauderdale, Florida



  
Medifocus Digest Alert is published monthly by Medifocus, Inc.
6810 Park Heights Avenue, Suite C5, Baltimore, MD 21215 USA
Copyright © 2013 Medifocus, Inc. All rights reserved.